This site is intended for healthcare professionals
Clinical trials
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • OctavaPink for Women With Dense Breast After Negat...
Clinical trial

OctavaPink for Women With Dense Breast After Negative Mammography

Read time: 1 mins
Last updated:29th Jul 2014

The OctavaPink test is indicated as an adjunct to mammography for breast cancer screening in asymptomatic women for whom screening or diagnostic mammography findings are normal or benign (BIRADS assessment category 1 or 2) and breast tissue is dense (BIRADS composition/density 3 or 4). The device is intended to increase breast cancer detection in the described patient population. Based upon the result of OctavaPink, the patient will be further evaluated by their physician.

Category Value
Study start date 2014-07-29

View full details